Trial Profile
Observational study investigating the long-term progression of ipilimumab-induced hypophysitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 19 Dec 2015 New trial record